Page last updated: 2024-10-29

iopromide and Coronary Restenosis

iopromide has been researched along with Coronary Restenosis in 9 studies

iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.

Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.

Research Excerpts

Excerpt	Relevance	Reference
"Paclitaxel and sirolimus increase apoptosis in either cell type."	1.37	Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells. ( Böhm, M; Clever, YP; Cremers, B; Krauss, B; Laufs, U; Scheller, B; Speck, U, 2011)

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (44.44)	29.6817
2010's	4 (44.44)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Zhu, J	1
Liu, L	1
Zhu, Z	1
Yang, Z	1
Hu, J	1
Ding, F	1
Zhou, Y	1
Su, X	1
Ge, J	1
Liu, X	1
Tang, L	1
He, Y	1
Zhou, G	1
Ji, Z	1
Li, Y	1
Pang, W	1
Zhang, R	1
Schröder, J	1
Vogt, F	1
Burgmaier, M	1
Reith, S	1
Almalla, M	1
Lee, YJ	1
Lim, YS	1
Lim, HW	1
Yoo, WJ	1
Choi, BG	1
Kim, BS	1
Clever, YP	1
Cremers, B	2
Krauss, B	1
Böhm, M	3
Speck, U	5
Laufs, U	1
Scheller, B	5
Rutsch, W	1
Borges, AC	1
Bräutigam, M	1
Clever, Y	1
Dietz, U	1
Richter, W	1
Romeike, B	1
Schmitt, A	2
Sovak, M	1
Stoll, HP	1
Nickenig, G	1
Abramjuk, C	1
Bernhardt, U	1
Stiller, W	1
Kobayashi, M	1
Koike, K	1
Stampfl, U	1
Richter, GM	1
Semmler, W	1
Kiessling, F	1

Clinical Trials (7)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent Restenoses: A Comparison to the Paclitaxel-Eluting Taxus™ Stent. A Pilot Study[NCT00393315]	Phase 2	120 participants (Actual)	Interventional	2005-11-30	Completed
Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR II)[NCT00409981]	Phase 1/Phase 2	56 participants	Interventional	2004-07-31	Completed
Treatment of In-Stent Restenosis by Paclitaxel Coated PTCA Balloons[NCT00106587]	Phase 1/Phase 2	52 participants (Actual)	Interventional	2003-12-31	Completed
Paclitaxel-Eluting PTCA-Balloon in Combination With the CoroflexTM Blue Stent vs the Sirolimus Coated CypherTM Stent in the Treatment of Advanced Coronary Artery Disease[NCT00473772]	Phase 1/Phase 2	643 participants (Actual)	Interventional	2007-07-31	Completed
Paclitaxel Coated Balloon Catheter for Inhibition of Restenosis in Femoropopliteal Arteries (PACCOCATH - FEM I)[NCT00472472]	Phase 1/Phase 2	87 participants (Actual)	Interventional	2004-04-30	Completed
Prospective Randomized Study of the Paclitaxel-Coated Balloon Catheter in Bifurcated Coronary Lesions / BABILON Study (Paclitaxel-Coated Balloon in Bifurcated Lesions)[NCT01278186]	Phase 4	190 participants (Anticipated)	Interventional	2010-06-30	Active, not recruiting
Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention (PacTAP Study): A Double Blind, Randomized Control Study[NCT01599078]		100 participants (Anticipated)	Interventional	2012-01-31	Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for iopromide and Coronary Restenosis

Article	Year
A randomized comparison of a novel iopromide-based paclitaxel-coated balloon Shenqi versus SeQuent Please for the treatment of in-stent restenosis. Coronary artery disease, 2021, Sep-01, Volume: 32, Issue:6 Topics: Angioplasty, Balloon, Coronary; China; Coated Materials, Biocompatible; Coronary Angiography; Corona	2021
Intracoronary local paclitaxel delivery by X-ray contrast media for in-stent restenosis: a clinical pilot study to assess safety and tolerability. Minerva cardioangiologica, 2012, Volume: 60, Issue:4 Topics: Aged; Algorithms; Cardiac Catheterization; Cardiovascular Agents; Contrast Media; Coronary Angiograp	2012

Other Studies

7 other studies available for iopromide and Coronary Restenosis

Article	Year
Long-term clinical outcomes after treatment of stent restenosis with two drug-coated balloons. Coronary artery disease, 2018, Volume: 29, Issue:8 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Butyrates; Cardiac Catheters; Cardiovascula	2018
Diagnostic accuracy of 64-slice multidetector CT angiography for detection of in-stent restenosis of vertebral artery ostium stents: comparison with conventional angiography. Acta radiologica (Stockholm, Sweden : 1987), 2014, Volume: 55, Issue:8 Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Area Under Curve; Contrast Media; Coronar	2014
Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Volume: 7 Suppl K Topics: Angioplasty, Balloon, Coronary; Animals; Apoptosis; Cardiovascular Agents; Cell Movement; Cell Proli	2011
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. European heart journal, 2003, Volume: 24, Issue:15 Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Ioh	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Co	2003
Drug delivery by angiographic contrast media: inhibition of restenosis. Academic radiology, 2005, Volume: 12 Suppl 1 Topics: Animals; Contrast Media; Coronary Angiography; Coronary Restenosis; Drug Carriers; Iodized Oil; Iohe	2005
Drug delivery by angiographic contrast media: inhibition of restenosis. Academic radiology, 2005, Volume: 12 Suppl 1 Topics: Animals; Contrast Media; Coronary Angiography; Coronary Restenosis; Drug Carriers; Iodized Oil; Iohe	2005
Drug delivery by angiographic contrast media: inhibition of restenosis. Academic radiology, 2005, Volume: 12 Suppl 1 Topics: Animals; Contrast Media; Coronary Angiography; Coronary Restenosis; Drug Carriers; Iodized Oil; Iohe	2005
Drug delivery by angiographic contrast media: inhibition of restenosis. Academic radiology, 2005, Volume: 12 Suppl 1 Topics: Animals; Contrast Media; Coronary Angiography; Coronary Restenosis; Drug Carriers; Iodized Oil; Iohe	2005
Initial Experience with a Novel Low-Dose Micro-CT System. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2007, Volume: 179, Issue:7 Topics: Animals; Coated Materials, Biocompatible; Contrast Media; Coronary Angiography; Coronary Restenosis;	2007